Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Equity (2016 - 2025)

Historic Return on Equity for Integra Lifesciences Holdings (IART) over the last 16 years, with Q3 2025 value amounting to 0.48%.

  • Integra Lifesciences Holdings' Return on Equity fell 4700.0% to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year decrease of 4700.0%. This contributed to the annual value of 0.0% for FY2024, which is 400.0% down from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Return on Equity is 0.48%, which was down 4700.0% from 0.39% recorded in Q2 2025.
  • Integra Lifesciences Holdings' Return on Equity's 5-year high stood at 0.13% during Q3 2021, with a 5-year trough of 0.48% in Q3 2025.
  • In the last 5 years, Integra Lifesciences Holdings' Return on Equity had a median value of 0.08% in 2023 and averaged 0.02%.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Return on Equity surged by 1400bps in 2021 and then tumbled by -4700bps in 2025.
  • Integra Lifesciences Holdings' Return on Equity (Quarter) stood at 0.1% in 2021, then rose by 0bps to 0.1% in 2022, then tumbled by -58bps to 0.04% in 2023, then tumbled by -111bps to 0.0% in 2024, then plummeted by -10438bps to 0.48% in 2025.
  • Its Return on Equity stands at 0.48% for Q3 2025, versus 0.39% for Q2 2025 and 0.02% for Q1 2025.